Enpatoran placebo, Enpatoran, Enpatoran clinical trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus and in Cutaneous Lupus Erythematosus (Subacute Cutaneous Lupus Erythematosus and/or Discoid Lupus Erythematosus) Participants Receiving Standard of Care

This study is testing a new medicine called Enpatoran for people with lupus that affects their whole body or their skin. Researchers want to see if it's safe and helps improve symptoms compared to a dummy drug, and find the best dose.